Analysis | Metabolite Name | Measured Value | Units | Cell Type | Stimulation |
---|---|---|---|---|---|
Reversed phase NEGATIVE ION MODE | GLUCOSE (CAS# 50-99-7); (2M+HCOO)-[-H2O] | 1095 | Peak area | HAHA | IFN-G |
Reversed phase NEGATIVE ION MODE | GLUCOSE (CAS# 50-99-7); (2M+HCOO)-[-H2O] | 1771 | Peak area | BS4 | IL-17A |
Reversed phase NEGATIVE ION MODE | GLUCOSE (CAS# 50-99-7); (2M+HCOO)-[-H2O] | 2521 | Peak area | HAHA | TNF-alpha |
Reversed phase NEGATIVE ION MODE | GLUCOSE (CAS# 50-99-7); (2M+HCOO)-[-H2O] | Peak area | BS4 | IFN-G | |
Reversed phase NEGATIVE ION MODE | GLUCOSE (CAS# 50-99-7); (2M+HCOO)-[-H2O] | Peak area | BS4 | TNF-alpha | |
Reversed phase NEGATIVE ION MODE | GLUCOSE (CAS# 50-99-7); (2M+HCOO)-[-H2O] | Peak area | BS4 | TNF-alpha+IL-17A | |
Reversed phase NEGATIVE ION MODE | GLUCOSE (CAS# 50-99-7); (2M+HCOO)-[-H2O] | Peak area | BS4 | Untreated | |
Reversed phase NEGATIVE ION MODE | GLUCOSE (CAS# 50-99-7); (2M+HCOO)-[-H2O] | Peak area | HAHA | IL-17A | |
Reversed phase NEGATIVE ION MODE | GLUCOSE (CAS# 50-99-7); (2M+HCOO)-[-H2O] | Peak area | HAHA | TNF-alpha+IL-17A | |
Reversed phase NEGATIVE ION MODE | GLUCOSE (CAS# 50-99-7); (2M+HCOO)-[-H2O] | Peak area | HAHA | Untreated | |
Reversed phase NEGATIVE ION MODE | GLUCOSE (CAS# 50-99-7); (2M+HCOO)-[-H2O] | Peak area | PAK | IFN-G | |
Reversed phase NEGATIVE ION MODE | GLUCOSE (CAS# 50-99-7); (2M+HCOO)-[-H2O] | Peak area | PAK | IL-17A | |
Reversed phase NEGATIVE ION MODE | GLUCOSE (CAS# 50-99-7); (2M+HCOO)-[-H2O] | Peak area | PAK | TNF-alpha | |
Reversed phase NEGATIVE ION MODE | GLUCOSE (CAS# 50-99-7); (2M+HCOO)-[-H2O] | Peak area | PAK | TNF-alpha+IL-17A | |
Reversed phase NEGATIVE ION MODE | GLUCOSE (CAS# 50-99-7); (2M+HCOO)-[-H2O] | Peak area | PAK | Untreated | |
Reversed phase NEGATIVE ION MODE | GLUCOSE (CAS# 50-99-7); (M+CL)- | 405012 | Peak area | HAHA | IFN-G |
Reversed phase NEGATIVE ION MODE | GLUCOSE (CAS# 50-99-7); (M+CL)- | 452247 | Peak area | BS4 | TNF-alpha+IL-17A |
Reversed phase NEGATIVE ION MODE | GLUCOSE (CAS# 50-99-7); (M+CL)- | 515699 | Peak area | PAK | TNF-alpha+IL-17A |
Reversed phase NEGATIVE ION MODE | GLUCOSE (CAS# 50-99-7); (M+CL)- | 524088 | Peak area | HAHA | TNF-alpha+IL-17A |
Reversed phase NEGATIVE ION MODE | GLUCOSE (CAS# 50-99-7); (M+CL)- | 534945 | Peak area | HAHA | IL-17A |
Reversed phase NEGATIVE ION MODE | GLUCOSE (CAS# 50-99-7); (M+CL)- | 561128 | Peak area | BS4 | IL-17A |
Reversed phase NEGATIVE ION MODE | GLUCOSE (CAS# 50-99-7); (M+CL)- | 579118 | Peak area | HAHA | TNF-alpha |
Reversed phase NEGATIVE ION MODE | GLUCOSE (CAS# 50-99-7); (M+CL)- | 580124 | Peak area | BS4 | TNF-alpha |
Reversed phase NEGATIVE ION MODE | GLUCOSE (CAS# 50-99-7); (M+CL)- | 581600 | Peak area | PAK | TNF-alpha |
Reversed phase NEGATIVE ION MODE | GLUCOSE (CAS# 50-99-7); (M+CL)- | 583882 | Peak area | HAHA | Untreated |
Reversed phase NEGATIVE ION MODE | GLUCOSE (CAS# 50-99-7); (M+CL)- | 636638 | Peak area | PAK | IL-17A |
Reversed phase NEGATIVE ION MODE | GLUCOSE (CAS# 50-99-7); (M+CL)- | 650952 | Peak area | BS4 | Untreated |
Reversed phase NEGATIVE ION MODE | GLUCOSE (CAS# 50-99-7); (M+CL)- | 976526 | Peak area | PAK | Untreated |
Reversed phase NEGATIVE ION MODE | GLUCOSE (CAS# 50-99-7); (M+CL)- | Peak area | BS4 | IFN-G | |
Reversed phase NEGATIVE ION MODE | GLUCOSE (CAS# 50-99-7); (M+CL)- | Peak area | PAK | IFN-G | |
Reversed phase POSITIVE ION MODE | GLUCOSE (CAS# 50-99-7); (2M+NA)+[-H2O] | 2760 | Peak area | PAK | IL-17A |
Reversed phase POSITIVE ION MODE | GLUCOSE (CAS# 50-99-7); (2M+NA)+[-H2O] | Peak area | BS4 | IFN-G | |
Reversed phase POSITIVE ION MODE | GLUCOSE (CAS# 50-99-7); (2M+NA)+[-H2O] | Peak area | BS4 | IL-17A | |
Reversed phase POSITIVE ION MODE | GLUCOSE (CAS# 50-99-7); (2M+NA)+[-H2O] | Peak area | BS4 | TNF-alpha | |
Reversed phase POSITIVE ION MODE | GLUCOSE (CAS# 50-99-7); (2M+NA)+[-H2O] | Peak area | BS4 | TNF-alpha+IL-17A | |
Reversed phase POSITIVE ION MODE | GLUCOSE (CAS# 50-99-7); (2M+NA)+[-H2O] | Peak area | BS4 | Untreated | |
Reversed phase POSITIVE ION MODE | GLUCOSE (CAS# 50-99-7); (2M+NA)+[-H2O] | Peak area | HAHA | IFN-G | |
Reversed phase POSITIVE ION MODE | GLUCOSE (CAS# 50-99-7); (2M+NA)+[-H2O] | Peak area | HAHA | IL-17A | |
Reversed phase POSITIVE ION MODE | GLUCOSE (CAS# 50-99-7); (2M+NA)+[-H2O] | Peak area | HAHA | TNF-alpha | |
Reversed phase POSITIVE ION MODE | GLUCOSE (CAS# 50-99-7); (2M+NA)+[-H2O] | Peak area | HAHA | TNF-alpha+IL-17A | |
Reversed phase POSITIVE ION MODE | GLUCOSE (CAS# 50-99-7); (2M+NA)+[-H2O] | Peak area | HAHA | Untreated | |
Reversed phase POSITIVE ION MODE | GLUCOSE (CAS# 50-99-7); (2M+NA)+[-H2O] | Peak area | PAK | IFN-G | |
Reversed phase POSITIVE ION MODE | GLUCOSE (CAS# 50-99-7); (2M+NA)+[-H2O] | Peak area | PAK | TNF-alpha | |
Reversed phase POSITIVE ION MODE | GLUCOSE (CAS# 50-99-7); (2M+NA)+[-H2O] | Peak area | PAK | TNF-alpha+IL-17A | |
Reversed phase POSITIVE ION MODE | GLUCOSE (CAS# 50-99-7); (2M+NA)+[-H2O] | Peak area | PAK | Untreated | |
Reversed phase POSITIVE ION MODE | GLUCOSE (CAS# 50-99-7); (M+NA)+ | 1140 | Peak area | BS4 | IFN-G |
Reversed phase POSITIVE ION MODE | GLUCOSE (CAS# 50-99-7); (M+NA)+ | 1229 | Peak area | PAK | IFN-G |
Reversed phase POSITIVE ION MODE | GLUCOSE (CAS# 50-99-7); (M+NA)+ | 3593 | Peak area | BS4 | TNF-alpha+IL-17A |
Reversed phase POSITIVE ION MODE | GLUCOSE (CAS# 50-99-7); (M+NA)+ | Peak area | BS4 | IL-17A | |
Reversed phase POSITIVE ION MODE | GLUCOSE (CAS# 50-99-7); (M+NA)+ | Peak area | BS4 | TNF-alpha | |
Reversed phase POSITIVE ION MODE | GLUCOSE (CAS# 50-99-7); (M+NA)+ | Peak area | BS4 | Untreated | |
Reversed phase POSITIVE ION MODE | GLUCOSE (CAS# 50-99-7); (M+NA)+ | Peak area | HAHA | IFN-G | |
Reversed phase POSITIVE ION MODE | GLUCOSE (CAS# 50-99-7); (M+NA)+ | Peak area | HAHA | IL-17A | |
Reversed phase POSITIVE ION MODE | GLUCOSE (CAS# 50-99-7); (M+NA)+ | Peak area | HAHA | TNF-alpha | |
Reversed phase POSITIVE ION MODE | GLUCOSE (CAS# 50-99-7); (M+NA)+ | Peak area | HAHA | TNF-alpha+IL-17A | |
Reversed phase POSITIVE ION MODE | GLUCOSE (CAS# 50-99-7); (M+NA)+ | Peak area | HAHA | Untreated | |
Reversed phase POSITIVE ION MODE | GLUCOSE (CAS# 50-99-7); (M+NA)+ | Peak area | PAK | IL-17A | |
Reversed phase POSITIVE ION MODE | GLUCOSE (CAS# 50-99-7); (M+NA)+ | Peak area | PAK | TNF-alpha | |
Reversed phase POSITIVE ION MODE | GLUCOSE (CAS# 50-99-7); (M+NA)+ | Peak area | PAK | TNF-alpha+IL-17A | |
Reversed phase POSITIVE ION MODE | GLUCOSE (CAS# 50-99-7); (M+NA)+ | Peak area | PAK | Untreated |